🇺🇸 FDA
Patent

US 10138466

Compositions and methods for differentiating stem cells into cell populations comprising beta-like cells

granted A61KA61K35/39A61K35/545

Quick answer

US patent 10138466 (Compositions and methods for differentiating stem cells into cell populations comprising beta-like cells) held by REGENERATIVE MEDICAL SOLUTIONS, INC. expires Mon Nov 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERATIVE MEDICAL SOLUTIONS, INC.
Grant date
Tue Nov 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K35/39, A61K35/545, A61K45/06, A61K9/1652